INGR
Ingredion Incorporated
96.50$
-0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.6% | 44.5% | 42.7% | 42.9% | 44.5% | 45.1% | 45.1% | 45.2% | 44.9% | 44.4% | 44.5% | 43.7% | |
| 4.4% | 5.2% | 6.0% | 7.0% | 11.7% | 13.4% | 11.2% | 11.1% | 11.7% | 13.0% | 11.5% | 11.7% | |
| 4.5% | 5.4% | 6.1% | 7.1% | 11.7% | 13.5% | 11.3% | 11.2% | 11.8% | 13.1% | 11.6% | 11.8% | |
| 18.3% | 16.7% | 17.5% | 17.8% | 15.6% | 14.7% | 17.2% | 17.5% | 16.7% | 15.0% | 17.1% | 17.2% | |
| 19.9% | 19.0% | 18.4% | 17.2% | 16.4% | 15.9% | 15.7% | 15.7% | 15.6% | 15.5% | 14.9% | 13.7% | |
| 31.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | 12.0% | 12.4% | 12.6% | 12.3% | 12.2% | – | – | – | 11.7% | 11.6% | 11.4% | |
| 17.2% | 5.0% | 5.1% | 5.1% | 4.9% | 4.8% | 16.9% | 16.5% | 16.3% | 16.1% | 15.9% | 4.2% | |
| 54.1% | 52.2% | 47.7% | 47.7% | 46.4% | 47.7% | 45.8% | 45.0% | 44.8% | 44.7% | 43.9% | 43.9% | |
| 22.1% | 23.2% | 17.5% | 17.0% | 16.7% | 17.2% | 15.8% | 16.2% | 16.3% | 16.7% | 16.1% | 15.6% | |
| 6.2% | 6.6% | 1.9% | 1.5% | 1.3% | 1.4% | 0.6% | 0.6% | 0.7% | 0.6% | 1.0% | 0.5% | |
| 14.9% | 10.2% | 9.0% | 8.4% | 8.0% | 8.1% | 8.5% | 8.6% | 15.6% | 16.1% | 7.7% | 15.1% | |
| 25.7% | 22.8% | 23.8% | 24.1% | 23.1% | 24.0% | 23.3% | 22.4% | 22.2% | 22.1% | 22.0% | 21.6% | |
| 45.2% | 47.0% | 51.5% | 52.0% | 53.2% | 51.9% | 53.8% | 54.6% | 54.8% | 55.0% | 55.8% | 56.1% | |
| 60.6% | 60.9% | 65.8% | 68.1% | 67.1% | 68.4% | 70.1% | 69.1% | 70.2% | 71.0% | 71.9% | 71.4% | |
| 0.9% | 0.9% | 0.9% | 0.9% | 0.9% | 0.9% | 0.9% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.